End to End Turnaround Strategy for At Risk Brands
We move beyond surface level fixes, combining market analysis, brand repositioning, and operational restructuring to drive a successful turnaround that rebuilds momentum and profitability.
Core Service: GTM Turnaround & Rescue Strategy
Is your product underperforming or has your launch stalled?
When a product loses momentum, every day is a loss of patent life. Solvencis performs a comprehensive GTM Audit to pivot toward profitability.
Root Cause Analysis
Identifying if the failure is due to pricing, positioning, or distribution friction.
Impact
Eliminates guesswork and targets the exact barrier to entry
Brand Revitalization
Re conceptualising the product optimally for a different patient segment.
Impact
Opens new revenue streams and reaches untapped markets.
Operational Restructuring
Streamlining sales force and marketing spend to maximize remaining patent life.
Impact
Enhances ROI by focusing resources where they actually convert.
The Solvencis Philosophy
Positioning the brand as a long term partner rather than a one time vendor.
Many products stumble because planning ends at launch. At Solvencis, we see GTM as a continuous lifecycle starting in early development and extending well beyond market entry. Our role doesn’t stop at launch execution; we stay engaged to strengthen performance, adapt to market realities, and drive sustainable scale.
Why Pharma Leaders Trust Us
Social proof and value proposition.
- Deep Domain Expertise: Specialized knowledge in regulatory landscapes and therapeutic nuances.
- Data Driven Pivots: We don’t rely on gut feelings; we use market analytics to drive our Turnaround Strategies.
- Maximizing Asset Value: We treat your product’s patent life as a finite, precious resource.
Our Thought Leadership
We are a multidisciplinary team of industry professionals who have worked inside pharma, biotech, and healthcare organizations. This real world experience allows us to deliver practical, execution ready strategies not just recommendations.
Caleb Benjamin Masih
Executive Director-Pharma Sales
A Pharmaceutical, Healthcare and Biotech Industry leader with 25+ years of experience across general management, sales, marketing, and operations. He has led global and Indian organisations, driving product launches, P&L performance, and scalable growth across the full product lifecycle
FAQs
We’ve Got You Covered!
How do we know if our product needs a “GTM Audit” versus just more time in the market?
Patience is important, but data is definitive. If your product is consistently missing internal benchmarks for 6+ months, or if prescriber feedback indicates “positioning confusion,” a GTM Audit is necessary. Our audit identifies whether the issue is a slow burn or a fundamental structural failure.
Is “Brand Revitalization” a fancy term for a simple rebranding exercise?
Not at all. While rebranding focuses on aesthetics, Brand Revitalization at Solvencis involves deep clinical and market re-evaluation. We look at shifting the product to a different patient segment or even a new therapeutic indication where the competition is lower and the need is higher.
How long does the “Root Cause Analysis” phase typically take?
We understand that every day a product underperforms is a day of lost patent life. Our accelerated Root Cause Analysis typically takes 4 to 6 weeks, delivering a comprehensive diagnostic report and an actionable turnaround roadmap.
Can Solvencis assist if our primary issue is Sales Force effectiveness?
Yes. Under our Operational Restructuring pillar, we analyze sales territory alignment, incentive structures, and messaging delivery. We help you streamline marketing spend and reorganize your field team to ensure they are targeting the highest-potential healthcare providers (HCPs).
How do you handle the “Sunk Cost Fallacy” when a product is failing?
Objectivity is our greatest asset. We provide an unbiased, data-driven perspective. If our audit suggests that a product is no longer viable in its current form, we provide the strategy to pivot resources toward more promising assets in your portfolio to protect your bottom line.
Does your GTM strategy account for varying global regulatory environments?
Absolutely. We recognize that pricing and distribution friction often stem from regional regulatory hurdles. Our strategies are modular, allowing for global consistency while adapting to local market access requirements and reimbursement landscapes.
Capturing the lead before they leave.
Don’t let a stalled launch define your product’s legacy. Let’s maximize your remaining patent life together.